MedPath

PHARMACY HEALTHCARE PTY LTD

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

17

TGA:17

Drug Approvals

Activated Methyl B12 (489132)

Product Name
Activated Methyl B12
Approval Date
May 19, 2025
TGA

Magzorb K2 + D3 (485811)

Product Name
Magzorb K2 + D3
Approval Date
Apr 11, 2025
TGA

L-Theanine PLUS (470153)

Product Name
L-Theanine PLUS
Approval Date
Nov 25, 2024
TGA

L-Theanine Plus (469971)

Product Name
L-Theanine Plus
Approval Date
Nov 22, 2024
TGA

NR Brain Boost (449052)

Product Name
NR Brain Boost
Approval Date
May 20, 2024
TGA

Ferrous+C (446952)

Product Name
Ferrous+C
Approval Date
Apr 29, 2024
TGA

MagZorb Calm (443114)

Product Name
MagZorb Calm
Approval Date
Mar 4, 2024
TGA

Immunity Boost Forte (443110)

Product Name
Immunity Boost Forte
Approval Date
Mar 4, 2024
TGA

NMN Boost (443115)

Product Name
NMN Boost
Approval Date
Mar 4, 2024
TGA

Berberine + (443113)

Product Name
Berberine +
Approval Date
Mar 4, 2024
TGA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.